Top Markets
#1 MowCat MowCat +48.44%
#2 Bermuda Shorts Bermuda Shorts +26.43%
#3 Velvet Velvet +25.14%
#4 Quack AI Quack AI +18.37%
#5 Biconomy Biconomy +18.22%
#6 Derive Derive +17.09%
#7 Block Street Block Street +15.53%
#8 DUSK Network DUSK Network +14.69%
#9 Perle Perle +14.22%
#10 Zerebro Zerebro +14.22%
Coin of the day
MowCat MowCat
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Imunon, Inc. Imunon, Inc.

Imunon, Inc.

CLSN
Clasificación en acciones #35102
Imunon, Inc. is a biotechnology firm in the clinical development stage,... Imunon, Inc. is a biotechnology firm in the clinical development stage, dedicated to innovating and commercializing DNA-centric immunotherapies, vaccines, and targeted chemotherapy solutions. Its primary pipeline assets include GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a unique formulation of doxorubicin encapsulated in heat-activated liposomes, currently being assessed for a variety of cancer indications. Furthermore, the company is advancing two early-phase platform technologies aimed at developing nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA treatments. Established in 1982, Imunon, Inc. maintains its operational base in Lawrenceville, New Jersey.
Precio por acción
$1.96
Última sincronización: 2022-09-20
Capitalización bursátil
$4.46M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Imunon, Inc. (CLSN)

Categoría

Healthcare
Ganancias de Imunon, Inc. (CLSN)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Imunon, Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Imunon, Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE